atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial...

Lobe Sciences Announces That Its Shares Will Trade on the OTCQB(R)...

PharmaDrug Announces Addition of Dr. Cindy Hutnik, President of the Canadian...

HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S....

atai Life Sciences Has Been Selected for Addition to the NASDAQ...

COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as...

Psychedelic Research Bulletin: November 2021

Psychedelic Bulletin: Our Dispatch from Horizons NYC; NIDA to Study Delix...

Numinus Wellness Inc. Reports Q4 and Year End 2021 Results

Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke...

Load more